Antigen-decorated shell cross-linked nanoparticles: Synthesis, characterization, and antibody interactions

Bioconjugate Chemistry

Volumn 16, Issue 5, 2005, Pages 1246-1256

  Joralemon, Maisie J ^a   Smith, Norah L ^b   Holowka, David ^b   Baird, Barbara ^b   Wooley, Karen L ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGENS; ATOM TRANSFER RADICAL POLYMERIZATION; ATOMIC FORCE MICROSCOPY; BIOCHEMISTRY; BLOCK COPOLYMERS; CARBOXYLIC ACIDS; DIFFERENTIAL SCANNING CALORIMETRY; DYNAMIC LIGHT SCATTERING; MICELLES; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL); THERMOGRAVIMETRIC ANALYSIS; ULTRAVIOLET VISIBLE SPECTROSCOPY; VIRUSES;

AMPHIPHILIC DIBLOCK COPOLYMERS; DEGRANULATION; DINITROPHENYL; NANO-SCALE SURFACES; NANOPARTICLE SYNTHESIS; POLY(ACRYLIC ACID); POLYMETHYL ACRYLATES; SHELL CROSS-LINKED KNEDEL-LIKE NANOPARTICLES; SHELL CROSS-LINKED NANOPARTICLES; SYNTHESISED;

HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY;

1 (3' DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE METHIODIDE; 2 BROMOPROPIONATE; 2,2' (ETHYLENEDIOXY)BIS(ETHYLAMINE); 2,4 DINITROPHENOL; ACRYLIC ACID COPOLYMER; ACRYLIC ACID METHYL ESTER; ACRYLIC ACID TERT BUTYL ESTER; AMINE; AMPHOPHILE; COPOLYMER; ETHYLAMINE; ETHYLENE DERIVATIVE; FLUORESCENT DYE; IMIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; METHYL IODIDE; NANOPARTICLE; POLYACRYLIC ACID; POLYMETHACRYLIC ACID DERIVATIVE; PROPIONIC ACID DERIVATIVE; TETRAHYDROFURAN; UNCLASSIFIED DRUG; WATER;

ALPHA CHAIN; ANTIGEN ANTIBODY REACTION; ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; ATOMIC FORCE MICROSCOPY; BIOAVAILABILITY; CELL LINE; CROSS LINKING; DEGRANULATION; DIFFERENTIAL SCANNING CALORIMETRY; HYDROPHILICITY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MICELLE; SURFACE PROPERTY; SYNTHESIS; THERMOGRAVIMETRY; TITRIMETRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; ULTRAVIOLET SPECTROSCOPY; VIRUS PARTICLE;

EID: 25444520240     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0501505     Document Type: Article

References (68)

1. Janeway, C. A. J., Travers, P., Walport, M., and Shlomchik, M. J. (2005) Immunobiology: the immune system in health and disease. Immunobiology: the immune system in health and disease, 6th ed., pp 1-3, 527-541, Garland Science Publishing, New York.
2. Cui, Z., Han, S.-J., Vangasseri, D. P., and Huang, L. (2005) Immunostimulation mechanism of LPD nanoparticles as a vaccine carrier. Mol. Pharm. 2, 22-28.
3. Huang, H.-I., Wu, P.-Y., Teo, C.-Y, Chen, M.-N., Chen, Y.-C., Silin, D., and Tao, M.-H. (2004) Improved immunogenicity of a self-tumor antigen, by covalent linkage to CD40 ligand Int. J. Cancer 108, 696-703.
4. Sedlik, C., Saron, M.-F., Sarraseca, J., Casal, L, and Leclerc, C. (1997) Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. U.S.A. 94, 7503-7508.
5. Saksena, R., Ma, X., and Ková, P. (2003) One-pot preparation of a series of glycoconjugates with predetermined antigen-carrier ratio from oligosaccharides that mimic the O-PS of Vibrio cholerae O:1, serotype Ogawa. Carbohydr. Res. 338, 2591-2603.
6. Glück, R., and Metcalfe, I. C. (2003) Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems. Vaccine 21, 611-615.
7. 90Y-labeled nanoparticles. Int. J. Radiat. Oncol. 58, 1215-1227.
8. Zurbiriggen, R., Novak-Hofer, L, Seelig, A., and Glück, R. (2000) IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog. Lipid Res. 39, 3-18.
9. Morein, B., Hu, K.-F., and Abusugra, I. (2004) Current status and potential applications of ISCOMs in veterinary medicine. Adv. Drug Delivery Rev. 56, 1367-1382.
10. Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewit, J., De Braekeleer, J., Jongert, E., and Borchard, G. (2003) Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int. J. Pharm. 266, 17-27.
11. Chew, J. L., Wolfowicz, C. B., Mao, H.-Q., Leong, K. W., and Chua, K. Y. (2003) Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 21, 2720-2729.
12. Sun, C.-J., Pan, S.-P., Xie, Q.-X., and Xiao, L.-J. (2004) Preparation of chitosan-plamid DNA nanoparticles encoding zona pellucida glycoprotein-3α and its expresstion in mouse. Mol. Reprod. Dev. 68, 182-188.
13. Yuan, R., Zhang, L., Li, Q., Chai, Y., and Cao, S. (2005) A label-free amperometric immunosensor based on multi-layer assembly of polymerized o-phenylenediamine and gold nanoparticles for determination of Japanese B encephalitis vaccine. Anal. Chim. Acta 531, 1-5.
14. Wu, Z.-S., Li, J.-S., Luo, M.-H., Shen, G.-L., and Yu, R.-Q. (2005) A novel capacitive immunosensor based on gold colloid monolayers associated with a sol-gel matrix. Anal. Chim. Acta 528, 235-242.
15. Huhtinen, P., Soukka, T., Lövgren, T., and Härmä, H. (2004) Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and strptavidin-biotin technology. J. Immunol. Methods 294, 111-122.
16. Svarovsky, S. A., Szekely, Z., Barchi, J. J. J. (2005) Synthesis of gold nanoparticle bearing the Thomsen-Friedenreich disacchardie: a new multivalent presentation of an important tumor antigen. Tetrahedron: Asymmetry 16, 587-598.
17. Prokop, A., Kozlov, E., Newman, G. W., and Newman, M. J. (2002) Water-based nanoparticulate polymeric system for protein delivery: Permeability control and vaccine application. Biotechnol. Bioeng. 78, 459-466.
18. Schöll, I., Weissenböck, A., Förster-Waldl, E., Untersmayr, E., Walter, F., Willheim, M., Boltz-Nitulescu, G., Scheiner, O, Gabor, F., and Jensen-Jarolim, E. (2004) Allergen-loaded biodegradable poly(D, L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin. Exp. Allergy 34, 315-321.
19. Sadler, K., and Tarn, J. P. (2002) Peptide dendrimers: Applications and synthesis Reviews in Molecular Biotechnology 90, 195-229.
20. Roy, R., and Kim, J. M. (2003) Cu(II)-self-assembling bipyridyl-glycoclusters and dendrimers bearing the Tn-antigen cancer marker: Syntheses and lectin binding properties. Tetrahedron 59, 3881-3893.
21. Gillies, E. R., and Fréchet, J. M. J. (2005) Dendrimers and dendritic polymers in drug delivery. Drug Discovery Today 10, 35-43.
22. Cui, Z., Patel, J., Tuzova, M., Ray, P., Phillips, R., Woodward, J. G., Nath, A., Mumper, R. J. (2004) Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Vaccine 22, 2631-2640.
23. Stevenson, A., and Roberts, M. (2004) Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC. Vaccine 22, 4300-4305.
24. Georgantas, R. W. I., Leong, K. W., and August, J. T. (2000) Antigen-specific induction of peripheral T cell tollerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand. Hum. Gene Ther. 11, 851-858.
25. Kelly, K. A., Allport, J. R., Tsourkas, A., Shinde-Patil, V. R., Josephson, L., and Weissleder, R. (2005) Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res. 96, 327-336.
26. Farokhazad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., Langer, R. (2004) Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res. 64, 7668-7672.
27. Felnerova, D., Viret, J.-F., Glück, R., Moser, C. (2004) Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr. Opin. Biotechnol. 15, 518-529.
28. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., Molema, G., Lu, P. Y.; S. P. V., and Woodle, M. C. (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149/1-e149/10.
29. Zhang, L., Hou, S., Mao, S., Wei, D., Song, X., and Lu, Y. (2004) Uptake of Mate-conjugated albumin nanoparticles to the SKOV3 cells. Int. J. Pharm. 287, 155-162.
30. Calvo, P., Gouritin, B., Brigger, I., Lasmezas, C., Deslys, J.-P., Williams, A., Andreux, J. P., Dormont, D., and Couvreur, P. (2001) PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases. J. Neurosci. Methods 111, 151-155.
31. Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M. A., Mirshahi, M., and Espuelas, S. (2005) Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini-Rev. Med. Chem. 5, 293-305.
32. Cui, Z., Han, S.-J., and Huang, L. (2004) Coating of mannan on LPD particles containg HPV E7 peptide significantly enhances immunity agains HPV-positive tumor. Pharmaceut. Res. 21, 1018-1025.
33. Prabha, S., and Labhasetwar, V. (2004) Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharm. 1, 211-219.
34. Williams, J., Lansdown, R., Sweitzer, R., Romanowski, M., LaBell, R., Ramaswami, R., and Unger, E. (2003) Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors. J. Controlled Release 91, 167-172.
35. Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., and Begley, D. J. (2003) Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharmaceut. Res. 20, 409-416.
36. 2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio applications. J. Mater. Chem. 14, 2781-2786.
37. Labhasetwar, V., Song, C., and Levy, R. J. (1997) Nanoparticle drug delivery system for restenosis. Adv. Drug Delivery Rev. 24, 63-85.
38. Thurmond, K. B., II, Kowalewski, T., and Wooley, K. L. (1996) Water-soluble knedel-like structures: The preparation of shell-cross-linked small particles. J. Am. Chem. Soc. 118, 7239-7240.
39. Wooley, K. L. (2000) Shell cross-linked polymer assemblies: Nanoscale constructs inspired from biological systems. J. Polym. Sci. Part A: Polym. Chem. 38, 1397-1407.
40. Huang, H., Kowalewski, T., and Wooley, K. L. (2003) Nanodroplets of polyisoprene fluid contained within poly-(acrylic acid-co-acrylamide) shells. J. Polym. Sci., Part A: Polym. Chem. 41, 1659-1668.
41. 3 receptor-ligand interactions. Macromolecules 37, 7109-7115.
42. Pan, D. J., Turner, L., and Wooley, K. L. (2003) Foilic acid-conjugated nanostructured materials designed for cancer cell targeting. Chem. Commun. 2400-2401.
43. Becker, M. L., Remsen, E. E., Pan, D., and Wooley, K. L. (2004) Peptide-derivatized shell-cross-linked nanoparticles. 1. Synthesis and characterization. Bioconjugate Chem. 15, 699-709.
44. Becker, M. L., Bailey, L. O., and Wooley, K. L. (2004) Peptide-derivatized shell-cross-linked nanoparticles. 2. Biocompatibility evaluation. Bioconjugate Chem. 15, 710-717.
45. Liu, J., Zhang, Q., Remsen, E. E., and Wooley, K. L. (2001) Nanostructured materials designed for cell binding and transduction Biomacromolecules 2, 362-368.
46. Qi, K., Ma, Q., Remsen, E. E., Clark, C. G. J., and Wooley, K. L. (2004) Determination of the bioavailability of biotin conjugated onto shell cross-linked (SCK) nanoparticles. J. Am. Chem. Soc. 126, 6599-6607.
47. Joralemon, M. J., Murthy, K. S., Remsen, E. E., Becker, M. L., and Wooley, K L. (2004) Synthesis, characterization, and bioavailability of mannosylated shell cross-linked nano-particles. Biomacromolecules 5, 903-913.
48. Becker, M. L., Liu, J., and Wooley, K. L. (2005) Functionalized Micellar Assemblies Prepared via Block Copolymers Synthesized by Living Free Radical Polymerization upon Peptide-loaded Resins. Biomacromolecules 6, 220-228.
49. Thurmond, K. B. I., Remsen, E. E., Kowalewski, T., and Wooley, K. L. (1999) Packaging of DNA by shell cross-linked nanoparticles. Nucleic Acids Res. 27, 2966-2971.
50. Sanji, T., Nakatsuka, Y., Ohnishi, S., and Sakurai, H. (2000) Preparation of nanometer-sized hollow particles by photochemical degradation of polysilane shell cross-linked micelles and reversible encapsulation of guest molecules. Macromolecules 33, 8524-8526.
51. Turner, J. L., and Wooley, K. L. (2004) Nanoscale cage-like structures derived from polyisoprene-containing shell cross-linked nanoparticle templates. Nano Lett. 4, 683-688.
52. Murthy, K. S., Ma, Q., Clark, C. G. J., Remsen, E. E., and Wooley, K. L. (2001) Fundamental design aspects of amphiphilic shell-cross-linked nanoparticles for controlled release applications. Chem. Commun. 773-774.
53. Huang, H., Wooley, K. L., and Schaefer, J. (2001) REDOR determination of the composition of shell cross-linked amphiphilic core-shell nanoparticles and the partitioning of sequestered fluorinated guests. Macromolecules 34, 547-551.
54. Kao, H.-M., O'Connor, R. D., Mehta, A. K., Huang, H., Poliks, B., Wooley, K. L., and Schaefer, J. (2001) Location of cholic acid sequestered by core-shell nanoparticles using REDOR NMR. Macromolecules 34, 544-546.
55. Yang, Z.-Q., Puffer, E. B., Pontrello, J. K., and Kiessling, L. L. (2002) Synthesis of a mulitvalent display of a CD22-binding trisaccharide. Carbohydr. Res. 337, 1605-1613.
56. Sulzer, B., and Perelson, A. S. (1997) Immunons revisted: Binding of multivalent antigens to B cells. Mol. Immunol. 34, 63-74.
57. Dower, S. K., DeLisi, C., Titus, J. A., and Segal, D. (1981) Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding. Biochemistry 20, 6326-6334.
58. Holowka, D., and Baird, B. (1996) Antigen-mediated IgE receptor aggregation and signaling: A window on cell surface structure and dynamics. Annu. Rev. Biophys. Biomol. Struct. 25, 79-112.
59. Baird, E., Holowka, D., Coates, G. W., and Baird, B. (2003) Highly effective poly(ethylene glycol) architectures for specific inhibition of immune receptor activation. Biochemistry 42, 12739-12748.
60. Barsumian, E. L., Isersky, C., Petrino, M. G., and Siraganian, R. P. (1981) IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol. 11, 317-323.
61. Erickson, J., Kane, P., Goldstein, B., Holowka, D., and Baird, B. (1986) Cross-linking of IgE-receptor complexes at the cell surface: A fluorescence method for studying the binding of monovalent and bivalent haptens to IgE. Mol. Immunol. 23, 769-781.
62. Weetall, M., Holowka, D., and Baird, B. (1993) Heterologous desensitization of high affinity receptor for IgE (FcεR1) on RBL cells. J. Immunol. 150, 4072-4083.
63. Eisen, H. N., Kern, M., Newton, W. T., and Helmreich, E. (1959) Distribution of 2,4-dinitrobenzene sensitizers between isolated lymphnode cells and extracellular medium in relation to induction of contact skin sensitivity. J. Exp. Med. 110, 187-206.
64. Zorina, L. N., Safiev, O. G., Rakhmankulov, D. L., and Paushkin, Y. M. (1989) Doklady akademii Nauk SSSR 308, 1150-1154.
65. Harris, N. T., Goldstein, B., Holowka, D., and Baird, B. (1997) Altered patterns of tyrosine phosphorylation and Syk activation for sterically restricted cyclic dimers of IfE-FcεRI. Biochemistry 36, 2237-2242.
66. Naal, R. M. Z. G., Tabb, J., Holowka, D., and Baird, B. (2004) In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells. Biosensors Bioelectronics 20, 791-796.
67. Murthy, K. S., Ma, Q., Remsen, E. E., Kowalewski, T., and Wooley, K. L. (2003) Thermal Shaping of Shell-crosslinked (SCK) Nanoparticles, Facilitated by Nanoconfinement of Fluid-like Cores J. Mater. Chem. 13, 2785-2795.
68. Turner, J., Chen, L. Z., and Wooley, K. L. (2005) Regiochemical Functionalization of a Nanoscale Cage-like Structure: Robust core-shell nanostructures crafted as vessels for selective uptake and release of small and large guests J. Controlled Release, in press.